Zobrazeno 1 - 10
of 1 302
pro vyhledávání: '"Haro JM"'
Autor:
Domenech C, Pastore A, Altamura AC, Bernasconi C, Corral R, Elkis H, Evans J, Malla A, Margari F, Krebs MO, Nordstroem AL, Zink M, Haro JM
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 3475-3486 (2019)
Cristina Domenech,1,2 Adriana Pastore,3 A Carlo Altamura,4 Corrado Bernasconi,5 Ricardo Corral,6 Helio Elkis,7 Jonathan Evans,8 Ashok Malla,9 Francesco Margari,3 Marie-Odile Krebs,10 Anna-Lena Nordstroem,5 Mathias Zink,11 Josep Maria Haro1,2 1Univers
Externí odkaz:
https://doaj.org/article/f94a265fc5ef4541b5d87dc25ae538c5
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 2313-2323 (2019)
Josep Maria Haro,1 Lene Hammer-Helmich,2 Delphine Saragoussi,3 Anders Ettrup,4 Klaus Groes Larsen51Research and Teaching Unit, Parc Sanitari Sant Joan De Deu, CIBERSAM, University of Barcelona, Sant Boi De Llobregat, Barcelona, Spain; 2Medical Affair
Externí odkaz:
https://doaj.org/article/cee693ba79ef4af7a93e98a0cacfc054
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 14, Pp 2473-2484 (2018)
Jia Huang,1 Yun Wang,1 Jun Chen,1 Yanlei Zhang,2 Zheng Yuan,2 Li Yue,2 Josep Maria Haro,3 Maria Victoria Moneta,3 Diego Novick,4 Yiru Fang1,5,6 1Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medici
Externí odkaz:
https://doaj.org/article/bb7b29fd6d9e4e7ba39a12595ce76382
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 14, Pp 1339-1350 (2018)
Delphine Saragoussi,1 Michael Cronquist Christensen,2 Lene Hammer-Helmich,3 Benoît Rive,4 Maëlys Touya,5 Josep Maria Haro6 1Real-World Evidence and Epidemiology, Lundbeck SAS, Issy-les-Moulineaux, France; 2Medical Affairs Vortioxetine, H. Lundbeck
Externí odkaz:
https://doaj.org/article/b350346aca85438eb85845a04360f92e
Autor:
Hammer-Helmich L, Haro JM, Jönsson B, Tanguy Melac A, Di Nicola S, Chollet J, Milea D, Rive B, Saragoussi D
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 14, Pp 239-249 (2018)
Lene Hammer-Helmich,1 Josep Maria Haro,2 Bengt Jönsson,3 Audrey Tanguy Melac,4 Sylvie Di Nicola,5 Julien Chollet,6 Dominique Milea,7 Benoît Rive,8 Delphine Saragoussi4 1Real World Evidence and Epidemiology, H Lundbeck A/S, Valby, Denmark; 2Research
Externí odkaz:
https://doaj.org/article/30a3f78dbf8645ebbfd997e74cb566fa
Publikováno v:
Clinical Epidemiology, Vol Volume 9, Pp 689-698 (2017)
Clementine Nordon,1 Constance Battin,1 Helene Verdoux,2 Josef Maria Haro,3 Mark Belger,4 Lucien Abenhaim,1 Tjeerd Pieter van Staa5 On behalf of the IMI GetReal WP2 Group 1Epidemiological Research, Analytica LASER, Paris, 2Population Health Research C
Externí odkaz:
https://doaj.org/article/2066d10e6a2a4b1e99d8d6a5ddac6f01
Publikováno v:
Patient Preference and Adherence, Vol Volume 11, Pp 1859-1868 (2017)
Diego Novick,1 William Montgomery,2 Ellen Vorstenbosch,3 Maria Victoria Moneta,3 Héctor Dueñas,4 Josep Maria Haro3 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Parc Sanitari Sant Joan de
Externí odkaz:
https://doaj.org/article/34f935e810c4463e8c655ae6d59965bc
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 13, Pp 2151-2165 (2017)
Delphine Saragoussi,1 Maëlys Touya,2 Josep Maria Haro,3 Bengt Jönsson,4 Martin Knapp,5 Bastien Botrel,6 Ioana Florea,7 Henrik Loft,8 Benoît Rive9 1Real-World Evidence and Epidemiology, Lundbeck SAS, Issy-les-Moulineaux, France; 2Health Economics a
Externí odkaz:
https://doaj.org/article/a118930eb9074b348715c38ad03d50bb
Publikováno v:
Patient Preference and Adherence, Vol Volume 11, Pp 1019-1025 (2017)
Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Ai Koyanagi,4 Jaume Aguado,4 Susanne Kraemer,5 Josep Maria Haro4 1Global Patient Outcomes and Real World Evidence (GPORWE), Eli Lilly and Company, Windlesham, Surrey, UK; 2Global Patient Outcomes and
Externí odkaz:
https://doaj.org/article/ed0c4aee490640f18b7640290271d3cb
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 12, Pp 2927-2939 (2016)
Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Maria Victoria Moneta,4 Josep Maria Haro4 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Eli Lilly and Company, Neuroscience Research, Budap
Externí odkaz:
https://doaj.org/article/31853c122c8e4fdf878927e63784e87a